drugset / Trial / NCT00798759

Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN

NCT00798759

Phase 4 Completed 236 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to compare two ophthalmic solutions in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2008-12
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical
Subject Travoprost Other / unclassified 0.004 % Topical